CRRTF
CRESCITA THERAPEUTICS ORD by Crescita Therapeutics Inc (CRRTF)
$02
About CRESCITA THERAPEUTICS ORD by Crescita Therapeutics Inc (CRRTF)
Crescita Therapeutics, Inc. engages in the provision of non-prescription skincare products. Its products include Pliaglis, Alyria, Laboratoire Dr Renaud, and Pro-Derm. It operates through the following business segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells non-prescription skincare products. The Licensing and Royalties segment refers to the licensing related to its prescription product. The Manufacturing and Services segment relates to the sale of topical products and product development services. The company was founded on March 1, 2016 and is headquartered in Laval, Canada.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.45
52 Week Low
$0.02
Market cap
390,900
Dividend yield
0.00%
Volume
--
Avg. volume
25
P/E ratio
1.09
CRESCITA THERAPEUTICS ORD by Crescita Therapeutics Inc News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.45
52 Week Low
$0.02
Market cap
390,900
Dividend yield
0.00%
Volume
--
Avg. volume
25
P/E ratio
1.09